Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Advances in the development of universal influenza vaccines.

Gilbert SC.

Influenza Other Respir Viruses. 2013 Sep;7(5):750-8. doi: 10.1111/irv.12013. Review.

2.

New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain.

Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM.

Vaccine. 2013 Apr 17;31 Suppl 1:A1-20. doi: 10.1016/j.vaccine.2013.02.033.

PMID:
23587330
3.

[Influenza, an existing public health problem].

García-García J, Ramos C.

Salud Publica Mex. 2006 May-Jun;48(3):244-67. Review. Spanish.

4.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.

BMC Infect Dis. 2011 Aug 26;11:230. doi: 10.1186/1471-2334-11-230.

5.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

WHO Writing Group., Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W.

Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x.

6.

Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals.

Strengell M, Ikonen N, Ziegler T, Kantele A, Anttila VJ, Julkunen I.

Influenza Other Respir Viruses. 2013 May;7(3):431-8. doi: 10.1111/j.1750-2659.2012.00415.x.

7.

New vaccine approaches for seasonal and pandemic influenza.

Palache B.

Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Review.

PMID:
18674583
8.

Pandemic preparedness: toward a universal influenza vaccine.

Roose K, Fiers W, Saelens X.

Drug News Perspect. 2009 Mar;22(2):80-92. doi: 10.1358/dnp.2009.22.2.1334451. Review.

PMID:
19330167
9.

Trends in development of the influenza vaccine with broader cross-protection.

Stropkovská A, Janulíková J, Varecková E.

Acta Virol. 2010;54(1):7-19. Review.

PMID:
20201609
10.

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.

Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.

Vaccine. 2011 Aug 11;29(35):5911-8. doi: 10.1016/j.vaccine.2011.06.068.

PMID:
21723354
11.

Universal influenza vaccines: a realistic option?

de Vries RD, Altenburg AF, Rimmelzwaan GF.

Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S120-S124. doi: 10.1016/j.cmi.2015.12.005.

PMID:
27130671
12.

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

Kodihalli S, Kobasa DL, Webster RG.

Vaccine. 2000 May 22;18(23):2592-9.

PMID:
10775793
13.

Influenza A viruses: why focusing on M2e-based universal vaccines.

Ebrahimi SM, Tebianian M.

Virus Genes. 2011 Feb;42(1):1-8. doi: 10.1007/s11262-010-0547-7. Review. Erratum in: Virus Genes. 2011 Feb;42(1):9.

PMID:
21082230
14.

Influenza vaccines: present and future.

Subbarao K.

Adv Virus Res. 1999;54:349-73.

PMID:
10547679
15.

Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.

[No authors listed]

Wkly Epidemiol Rec. 2012 Mar 16;87(11):97-108. English, French. No abstract available.

16.

FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007.

Eichelberger M, Golding H, Hess M, Weir J, Subbarao K, Luke CJ, Friede M, Wood D.

Vaccine. 2008 Aug 12;26(34):4299-303. doi: 10.1016/j.vaccine.2008.06.012.

PMID:
18582523
17.

Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.

Vemula SV, Ahi YS, Swaim AM, Katz JM, Donis R, Sambhara S, Mittal SK.

PLoS One. 2013 Apr 30;8(4):e62496. doi: 10.1371/journal.pone.0062496.

18.

Evolving strategies for the prevention of influenza infection: potential for multistrain targeting.

Livingston BD, Higgins D, Van Nest G.

BioDrugs. 2006;20(6):335-40.

PMID:
17176120
19.
20.

Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.

Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T; WHO Writing Group..

Vaccine. 2015 Aug 26;33(36):4368-82. doi: 10.1016/j.vaccine.2015.06.090.

Items per page

Supplemental Content

Support Center